Project Details
| Status | Active |
|---|---|
| Effective start/end date | 08/15/24 → 08/14/26 |
Funding
- Trustees of Indiana University: $105,355.00
A Phase I/II trial to evaluate the safety, pharmacodynamics and efficacy of MPDL3280A in combination with entinostat bevacizumab in patients with advanced renal cell carcinoma
- Pili, Roberto (PI)
Project: Research